With the rapid advancement of multi-omics technologies—including genomics, transcriptomics, epigenomics, and proteomics further integration with animal models to deeply investigate the genetic mechanisms of synchronous ascending colon cancer and papillary renal cell carcinoma will be highly significant for advancing clinical precision diagnosis, treatment, and prognosis ( 10 ).
← all excerpts
Case report: Minimally invasive management of synchronous early-stage ascending colon adenocarcinoma and type 1 papillary renal cell carcinoma presenting with severe anemia: a rare Chinese case.
1
—
—